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CCAAT/enhancer binding proteins (C/EBP) have been shown to be required for HIV-1 transcription and replication in
macrophages. However, whether these transcription factors influence the ability of virus to establish infection by altering
cytokine or receptor expression or primarily regulate HIV-1 transcription has not been determined. By inhibiting endogenous
C/EBP activity with a dominant-negative protein, we demonstrate that functional C/EBPs are not required for HIV-1 infection
and that these factors influence replication by a transcriptional mechanism. C/EBP recruits coactivators to the HIV-1
long-terminal repeat (LTR) and physically interacts with histone acetyltransferase (HAT) complexes, suggesting that C/EBPs
participate in remodeling the chromatin organization of the HIV-1 provirus. Furthermore, overexpression of a C/EBP
dominant-negative inhibits displacement of nucleosomes located at the HIV-1 transcriptional start site. These results provide
insight into the general mechanisms by which C/EBPs regulate macrophage-restricted HIV-1 transcription. © 2002 ElsevierINTRODUCTION
HIV-1 transcription is controlled by cellular and viral
factors that bind the HIV-1 long-terminal repeat (LTR)
(Gaynor, 1992). NF-B is one cellular factor that has been
shown to be important in regulating HIV-1 expression.
Recent experiments demonstrated that CCAAT/enhancer
binding proteins (C/EBP) are also necessary for HIV-1
replication in macrophages and suggested that C/EBP
is a macrophage-specific requirement for virus transcrip-
tion (Henderson et al., 1996; Henderson and Calame,
1997; Tesmer et al., 1993). C/EBP family members are
expressed in several tissues but have distinct expres-
sion patterns. For example, C/EBP is induced during
monocytic cell differentiation and coordinates the ex-
pression of several genes during macrophage activation
(Akira and Kishimoto, 1992; Poli, 1998). When infected
macrophages are activated, HIV-1 transcription in-
creases, partly due to induction of NF-B and C/EBP
activities (Griffin et al., 1989; Henderson et al., 1996;
Henderson and Calame, 1997; Jacque et al., 1996).
Whether the induction of transcription factors such as
C/EBP solely regulate transcription or indirectly influ-
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20ence HIV-1 replication by modifying the expression of
receptors or cytokines and thus the susceptibility of
monocytes/macrophages to HIV-1 infection has not been
examined.
The general mechanism by which C/EBPs regulate
HIV-1 transcription is also not known. Although C/EBPs
are necessary for HIV-1 expression and replication in
macrophages (Henderson et al., 1996; Henderson and
Calame, 1997), overexpression of C/EBP is not suffi-
cient to activate latent virus expression, indicating that
posttranslation events are necessary for this factor to
induce HIV-1 transcription (Henderson et al., 1996). One
explanation for this observation is that the ability of
C/EBP to activate HIV-1 transcription is dependent on
functional interactions with other factors. C/EBP has
been shown to interact with several classes of transcrip-
tion factors including transcriptional coactivators Swi/Snf
and CBP/p300. Furthermore, it has been suggested that
by interacting with these coactivators C/EBP potentially
influences chromatin organization (Kowenz-Leutz and
Leutz, 1999; Mink et al., 1997; Oelgeschlager et al., 1996).
HIV-1 expression is associated with displacement of
nucleosomes and establishment of an open chromatin
structure (El Kharroubi et al., 1998; Sheridan et al., 1997;
Van Lint et al., 1996; Verdin, 1991; Verdin et al., 1993).
CBP/p300 has been shown to functionally and physically
interact with multiple factors that bind the LTR including
NF-B, Sp1, and Tat (Benkirane et al., 1998; Hottiger et al.,Science (USA)
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Berghe et al., 1999). Chromatin-dependent in vitro tran-
scription systems have also demonstrated a critical role
for T cell-restricted factors TCF-1/LEF-1 and Ets-1 in
remodeling the HIV-1 LTR (Pazin et al., 1996; Steger and
Workman, 1997). Factors that recruit chromatin remodel-
ing complexes to the LTR in cells other than T cells have
not been examined.
In this study we were interested in characterizing in
greater detail the mechanisms by which C/EBPs regulate
HIV-1 replication. We utilize monocytic cell lines that
ectopically express a dominate-negative protein to in-
hibit endogenous functional C/EBPs. Our data show that
C/EBP factors are not necessary for establishing HIV-1
infection in monocytic cells but primarily influence HIV-1
replication at a transcriptional level in part by reorganiz-
ing the chromatin structure of the HIV-1 proviral LTR.
RESULTS
C/EBP factors do not influence HIV entry but are
necessary for efficient HIV-1 transcription in
monocytic cells
Previous studies have shown that HIV-1 fails to pro-
ductively infect monocytic cells overexpressing the
C/EBP dominant-negative protein LIP (Henderson et al.,
1996; Henderson and Calame, 1997). LIP, which lacks a
strong transcriptional activation domain, inhibits C/EBP
by forming antagonistic homodimers or nonfunctional
C/EBP-LIP heterodimers (Descombes and Schibler,
1990). To assess the importance of functional C/EBP
factors during HIV-1 replication in monocytic cells, we
infected U937 monocytic cells and U937 cells overex-
pressing LIP (U937-LIP) with a replication-competent
GFP-tagged NL43 virus (HIV-GFP) to quantify the number
of infected cells. Infection was monitored by flow cytom-
etry and RT assays. The difference in the number of U937
and U937-LIP cells infected is not significant at the ear-
lier times postinfection but the effects of LIP overexpres-
sion on HIV-1 infection become increasingly evident with
time (Fig. 1). Twenty-four hours postinfection, equivalent
numbers of U937 and U937-LIP cells were infected with
HIV-GFP and by 2–3 days postinfection, twofold less
U937-LIP cells were infected with HIV-GFP compared to
U937 cells (Fig. 1A). Three weeks postinfection, U937
cells produced a significant amount of virus as indicated
by RT activity (Fig. 1B) and 15–20% of the cells were
infected as determined by GFP expression (Fig. 1C)
whereas, consistent with previous studies (Henderson
and Calame, 1997), U937-LIP cells expressed 100-fold
less virus compared to U937 cells and very few cells
were HIV-1 positive (Figs. 1B and 1C). These data sug-
FIG. 1. C/EBP factors are necessary for HIV-1 replication in monocytes. (A) U937 and U937-LIP cells were infected with HIV-GFP and analyzed for
infected cells at 24, 48, and 72 h postinfection by flow cytometry. (B) U937 and U937-LIP cells were infected with HIV-GFP and supernatants were
assayed for RT activity 3 weeks postinfection. Each data point represents three independent infections. Error bars show one standard deviation.
These results are representative of three separate experiments. (C) U937 and U937-LIP cells were infected with HIV-GFP and analyzed by flow
cytometry for infected cells 3 weeks postinfection.
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gest that functional C/EBP factors are required for pro-
ductive replication of HIV-1 in monocytic cells.
The inability of the virus to replicate in cells overex-
pressing LIP could be due to a block in virus entry,
possibly at the level of coreceptor usage. HIV-1 requires
CD4 and a chemokine receptor, in particular CXCR4 or
CCR5, to infect the host cell. Changes in the levels of
these receptors have been shown to alter susceptibility
to HIV-1 infection (Basta et al., 1999; Berger et al., 1999;
Franchin et al., 2000; Moriuchi et al., 1998; Tuttle et al.,
1998). To assure that C/EBP factors were not adversely
influencing HIV-1 infection by altering the expression of
CD4 or chemokine receptors, we used flow cytometry
and semiquantitative RT-PCR to analyze U937 and U937-
LIP cells for the expression of these receptors. When
U937 and U937-LIP cells were analyzed for CD4, no
significant difference in mRNA levels or surface expres-
sion was observed (Figs. 2A and 2B). Similarly, CXCR4
expression was unchanged between U937 and U937-LIP
cells (Figs. 2C and 2D). Although there are slight shifts in
the fluorescence intensity in CD4 and CXCR4 between
U937 and U937-LIP cells, these changes represent less
than a twofold difference in mean fluorescence intensity
(mean fluorescence intensity for CD4, U937 128, U937-
LIP  72; mean fluorescence intensity for CXCR4, U937 
15.1, U937-LIP  27.7). Both cell types downregulated
CXCR4 expression in response to PMA treatment, which is
consistent with previous reports (Fig. 2C) (Moriuchi et al.,
1998). Neither unstimulated nor stimulated U937 and U937-
LIP cells expressed detectable levels of CCR5 as deter-
mined by RT-PCR and flow cytometry (data not shown).
Therefore, LIP overexpression does not affect CD4 and
CXCR4 expression, suggesting that endogenous C/EBPs
are not required for HIV-1 infection of monocytic cells.
To confirm that U937 and U937-LIP cells were equally
susceptible to HIV-1 infection, cells were infected with a
replication-incompetent virus in which the envelope
gene (Env) was replaced with a luciferase reporter gene
(HIV-luc). Genomic DNA was prepared 48 h postinfection
and assayed for proviral sequences using PCR. As
shown in Fig. 3A, U937 and U937-LIP cells had similar
levels of HIV-1 provirus, demonstrating that LIP did not
block viral entry and that functional C/EBP proteins are
not required for establishing HIV-1 infection.
FIG. 2. C/EBP factors do not regulate expression of coreceptors necessary for HIV-1 infection. (A) U937 and U937-LIP cells were analyzed for CD4
expression by RT-PCR on total RNA or (B) by flow cytometry following staining with anti-CD4 antibody (solid line) or IgG isotype matched control (broken
line). (C) Total RNA was prepared from U937 and U937-LIP cells cultured alone or with 10 ng/ml PMA for 6–12 h and analyzed by RT-PCR for CXCR4
expression. (D) Cells were stained with anti-human CXCR4 antibody (solid line) or IgG isotype matched control (broken line) and analyzed by flow cytometry.
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The lack of a role for C/EBP factors in establishing
infection suggests that the inhibition of HIV-1 replication
in monocytic cells overexpressing LIP is through a direct
effect on virus transcription. To investigate this possibil-
ity, HIV-luc was used to infect U937 and U937-LIP cells
and virus transcription was measured by luciferase ac-
tivity 48 h postinfection. As shown in Fig. 3B, a sixfold
decrease in luciferase activity was observed in U937-LIP
cells compared to U937 cells. These data support the
conclusion that C/EBP factors are influencing HIV-1 rep-
lication in monocytic cells through a transcriptional
mechanism.
C/EBP requires coactivators to transactivate the
HIV-1 LTR
Functional C/EBPs are necessary but not sufficient for
HIV-1 transcription in macrophages (Henderson et al.,
1996; Henderson and Calame, 1997) and may require
interactions with other transcription factors or coactiva-
tors. To determine whether functional interactions be-
tween coactivators and C/EBP were relevant for HIV-1
LTR activity, we performed cotransfection experiments
using a HIV-1 LTR-luciferase reporter and different com-
binations of expression constructs encoding C/EBP
and CBP. Consistent with previous studies C/EBP was
able to strongly transactivate the HIV-1 LTR (Henderson
et al., 1995; Tesmer et al., 1993). Ectopic expression of
CBP was also able to activate the HIV-1 LTR in a dose-
dependent manner. However, cotransfecting with both
C/EBP and CBP led to synergistic activation of the
HIV-1 LTR. As shown in Fig. 4 cotransfections with both
CBP and C/EBP resulted in a 56-fold increase in HIV-1
LTR activity, whereas approximately 10-fold increases in
transcriptional activity were observed with C/EBP or
CBP alone (Fig. 4A). These results are not due to CBP
increasing C/EBP expression since immunoblots dem-
onstrate that cells have approximately equivalent levels
of C/EBP in the absence or presence of exogenous
CBP (data not shown). Furthermore, C/EBP-binding ac-
tivity is unaffected by CBP overexpression (Fig. 4D).
These data would suggest that C/EBP functionally in-
teracts with CBP and that CBP is a limiting factor for this
activity.
Although CBP has histone acetyltransferase (HAT) ac-
tivity, this coactivator functions in part by recruiting other
HAT coactivators including PCAF to the promoter (Yang
et al., 1996). Therefore, additional cotransfection experi-
ments were performed to determine whether C/EBP
and PCAF were able to cooperatively activate the HIV-1
LTR. Similar to the previous experiment, PCAF enhanced
the ability of C/EBP to transactivate the HIV-1 LTR (Fig.
4B). This enhancement is not due to PCAF altering
C/EBP binding activity, which remains unchanged in
the absence or presence of PCAF (Fig. 4E). These data
indicate that coactivators can interact with C/EBP to
influence HIV-1 expression and are limiting the ability of
C/EBP to fully induce HIV-1 transcription. Furthermore,
ectopic expression of E1a, which binds directly to CBP/
p300 and PCAF thereby inhibiting their activity (Chakra-
varti et al., 1999; Hamamori et al., 1999), decreases
C/EBP-dependent HIV-1 LTR activity. The ability of
C/EBP to transactivate the HIV-1 LTR was reduced by
greater than 80% and this inhibition could be overcome
by overexpression of either CBP or PCAF (Fig. 4C and
data not shown), indicating that E1a inhibits the HIV-1
LTR by competing with C/EBP for coactivators. These
data demonstrate that C/EBP activates HIV-1 transcrip-
tion by recruiting HAT coactivators to the promoter.
C/EBP interacts with chromatin remodeling
complexes
PCAF participates in large multi-subunit HAT com-
plexes that are analogous to SAGA and Ada in yeast.
FIG. 3. C/EBP factors regulate HIV-1 replication in monocytes directly
through a transcriptional mechanism. (A) U937 and U937-LIP cells were
infected with HIV-luc and genomic DNA was prepared 48 h postinfec-
tion. Measures of 1, 0.1, or 0.01 g genomic DNA were analyzed by PCR
for proviral sequences. U937-LIP3 and U937-LIP4 refer to different
clonal populations of cells. (B) Forty-eight hours postinfection with
HIV-luc, U937 and U937-LIP cells were lysed and assayed for luciferase
activity. These results are from a single experiment performed in
triplicate and represent three independent experiments. Error bars
show one standard deviation.
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Native HATs purified from yeast have been well charac-
terized and demonstrated to interact with transcription
factors from higher eukaryotes (Grant et al., 1997; Howe
et al., 1999; Sterner and Berger, 2000; Wallberg et al.,
1999). Furthermore, yeast HATs have been shown to
reorganize preassembled HIV-1 chromatin templates
and stimulate transcription in vitro (Steger et al., 1998).
Since the yeast HATs are structurally and functionally
similar to the mammalian complexes (Howe et al., 1999;
Ogryzko et al., 1998; Sterner and Berger, 2000; Vassilev et
al., 1998), we examined the ability of C/EBP to bind
SAGA using a GST pull-down assay. After incubating
purified SAGA with glutathione-Sepharose beads and
GST-C/EBP fusion protein, both beads and supernatant
were assayed for HAT activity. Figure 5A shows HAT
activity was retained on the GST-C/EBP-bound beads
while no significant HAT activity was observed with
beads alone. These data indicate that C/EBP directly
interacts with HAT complexes and suggest that C/EBP
in part regulates HIV-1 transcription by recruiting nucleo-
some-acetylating native complexes to the LTR.
To further explore the significance of the above inter-
action, we tested whether PCAF, the mammalian ho-
molog of the GCN5 subunit of yeast SAGA, specifically
interacts with C/EBP in a cellular system. 293T cells
were transiently transfected with PCAF and C/EBP and
nuclear extracts were analyzed for protein interactions
by coimmunoprecipitation. As shown in Fig. 5B, immu-
noprecipitation with anti-C/EBP antibody pulled-down
PCAF, demonstrating a physical interaction between
FIG. 4. C/EBP cooperates with CBP to activate the HIV-1 LTR. (A) Five micrograms of LTR-LUC reporter was cotransfected into 293T cells with
0 or 5 g of C/EBP and 0, 1, 2, and 5 g of CBP or (B) 0, 1, 3, 5, or 7 g of PCAF or (C) 0, 1, 2, and 5 g of 12S E1a as indicated. Forty-eight hours
posttransfection, cells were collected and luciferase activity was measured. Each bar represents three independent transfections. These data are
from single experiments that are representative of four independent experiments. (D) EMSA were performed with nuclear extracts prepared from 293T
cells cotransfected with 0 or 5 g of C/EBP and 0, 1, 2, or 5 g of CBP (Lanes 2, 4–6) and a C/EBP binding site oligonucleotide probe. Extracts were
incubated with no competitor (Lanes 1–6), a 50-fold excess of specific C/EBP binding site competitor (Lanes 7–12), or a 50-fold excess of nonspecific
NF-B binding site competitor (Lanes 13–18). (E) EMSA were performed with nuclear extracts prepared from 293T cells cotransfected with 0 or 5 g
of C/EBP and 0, 3, or 5 g of PCAF (Lanes 1, 3, 4) and a C/EBP binding site oligonucleotide probe. Extracts were incubated with no competitor (Lanes
1–4), a 50-fold excess of specific C/EBP binding site competitor (Lanes 5–8), or a 50-fold excess of nonspecific NF-B binding site competitor (Lanes
9–12).
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PCAF and C/EBP. However, we were unable to coim-
munoprecipitate PCAF from cell extracts with transfected
LIP, which lacks the N-terminal transactivation domain
(Fig. 5B). These results demonstrate that C/EBP phys-
ically interacts with components of SAGA in a cellular
context and that the transactivation domain of C/EBP
mediate this interaction.
Inhibiting endogenous C/EBPs prevents chromatin
remodeling of the HIV-1 LTR
We have used transient transfections to suggest a
functional interaction between C/EBP and HATs; how-
ever, the majority of the transfected DNA is unintegrated
and, although associated with histones, would be ex-
pected to have a simpler chromatin structure. Therefore,
it is critical that we employ a relevant cell type containing
integrated HIV-1 provirus. U1 monocytic cells harbor la-
tent provirus and C/EBP has been demonstrated to be
required for induction of virus expression (Henderson et
al., 1996). In addition, the induction of HIV-1 transcription
in these cells is associated with displacement of a nu-
cleosome positioned at the transcriptional start site (Ver-
din et al., 1993). To determine whether functional C/EBP
is required for remodeling the chromatin structure of the
HIV-1 proviral LTR, we took advantage of U1 lines that
ectopically express the C/EBP dominant-negative pro-
tein, LIP (Henderson et al., 1996). Transcriptional induc-
tion is associated with an open chromatin structure,
which can be detected by increased sensitivity to restric-
tion enzymes (El Kharroubi et al., 1998; Verdin et al.,
1993). Upon activation with PMA, which induces U1 HIV-1
transcription, the nucleosome positioned at 2 to 142
is displaced, making this region susceptible to HindIII
and PstI digestion (Fig. 6B and data not shown) (Verdin et
al., 1993). Other restriction sites that are adjacent to the
positioned nucleosome, such as PvuII, generate frag-
ments regardless of whether U1 cells have been acti-
vated (Fig. 6B) (Verdin et al., 1993). When U1-LIP cells
were treated with PMA, consistent with previous studies,
virus replication was significantly reduced (Fig. 6A) (Hen-
derson et al., 1996). More importantly, despite detecting
a PvuII-specific restriction fragment, HindIII did not effi-
ciently digest DNA from nuclei obtained from activated
U1-LIP cells (Figs. 6C and 6D). Therefore, inhibiting en-
dogenous C/EBPs prevents the displacement of the nu-
cleosome at the HIV-1 transcriptional start site. Since
C/EBP is the primary C/EBP family member induced
following activation of U1 cells (Natsuka et al., 1992),
these results suggest that by recruiting chromatin re-
modeling complexes to the LTR, C/EBP regulates HIV-1
transcription.
DISCUSSION
Previous studies have shown that the transcriptional
activator C/EBP activates the HIV-1 LTR and is neces-
sary for HIV-1 replication in monocytes (Henderson et al.,
1996; Henderson and Calame, 1997; Tesmer et al., 1993).
However, the role of C/EBP in establishing HIV-1 infec-
tion has not been determined. We demonstrate that while
C/EBP factors are not necessary for establishing HIV-1
infection of monocytes they influence HIV-1 replication
by regulating the chromatin structure of the LTR and thus
virus transcription.
C/EBP has been shown to control the expression of
a number of genes during macrophage activation includ-
ing CD14, ICAM-1, Mac-1, and IL-6, which are expressed
at significantly lower levels in cell lines that ectopically
express the C/EBP dominant-negative protein LIP (Hen-
derson et al., 1996; Henderson, A. J., Lee, E. S., and Zhou,
H., unpublished data). However, as shown in this study,
the expression of receptors essential for HIV-1 infection,
CD4 and CXCR4, does not require functional endoge-
nous C/EBPs. Furthermore, inhibition of C/EBP activity in
monocytic cells does not adversely affect HIV-1 infection.
We were unable to detect CCR5 expression in U937 cells
and therefore could not evaluate whether this chemokine
receptor is potentially regulated by C/EBPs in mono-
cytes/macrophages, although the promoter for CCR5 has
been recently characterized and does have potential
C/EBP binding sites (Moriuchi et al., 1997; Rosati et al.,
2001). While these data suggest that C/EBP factors do
FIG. 5. C/EBP interacts with chromatin remodeling complex SAGA.
(A) GST pull-down assays were performed with either GST-C/EBP,
mock-transformed bacterial extracts, or GST bound to glutathione-
Sepharose beads. SAGA purified from yeast was incubated with the
protein–bead complexes as described under Materials and Methods.
Supernatants and beads were assayed for their ability to acetylate core
histones as described under Materials and Methods. (B) 293T cells
were transfected with 0 or 1 g of PCAF and 0 or 5 g of C/EBP or LIP.
Nuclear extracts were immunoprecipitated with anti-C/EBP antibody
and Western blotting was performed to detect PCAF and C/EBP pro-
teins.
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not directly affect HIV-1 infection in monocytes, C/EBPs
may indirectly influence disease progression by contrib-
uting to aberrant macrophage function, inappropriate ex-
pression of inflammatory cytokines, and a more permis-
sive microenvironment for disease progression (Akira
and Kishimoto, 1992; Honda et al., 1998; Lee et al., 2001).
Although C/EBP does not influence HIV-1 infection,
this factor impacts HIV-1 replication by regulating virus
transcription in part through the recruitment of coactiva-
tors to the LTR. It has been demonstrated that activation
of latent HIV-1 proviral expression in monocytic and T
cell lines is associated with specific chromatin changes
within the 5 LTR, including displacement of a nucleo-
some positioned at the transcriptional start site (El Khar-
roubi et al., 1998; Verdin, 1991; Verdin et al., 1993). Fur-
thermore, treatment of cell lines harboring latent HIV-1
provirus with trichostatin A, trapoxin, or sodium butyrate,
specific inhibitors of histone deacetylases, induces virus
expression indicating that HIV-1 transcription is depen-
dent on histone acetylation (Laughlin et al., 1993; Van Lint
et al., 1996). The importance of histone acetylation and
chromatin remodeling by HATs has been confirmed us-
ing nucleosome-associated HIV-1 templates with in vitro
transcription systems (Pazin et al., 1996; Sheridan et al.,
1995, 1997; Steger et al., 1997, 1998; Widak et al., 1997).
Transcription factors such as NF-B, SP1, Ets-1, and
LEF-1, which bind the proviral enhancer/promoter lo-
cated in the site upstream of the nucleosome core par-
ticle, participate in reorganizing chromatin by facilitating
the recruitment of HAT coactivators to the LTR (Pazin et
al., 1996; Sheridan et al., 1995, 1997; Steger et al., 1997,
1998; Widak et al., 1997). However, the transcription fac-
tors Ets-1 and LEF-1 are restricted to T cells and it would
be expected that macrophage-restricted factors may
also interact with chromatin-remodeling complexes. Our
results show that C/EBP functionally interacts with HAT
coactivators and physically interacts with chromatin re-
modeling complexes in monocytic cells, demonstrating
that coactivators are critical for the ability of C/EBP to
induce HIV-1 transcription. However, it is unclear the
exact role chromatin remodeling plays during de novo
infection since the number of cells with latent provirus is
estimated to be low, although reactivation of virus ex-
pression in these cells may be a major source of HIV-1 at
late stages of infection or upon removal of anti-retroviral
treatments (McCune, 1995).
Previous work by Mink et al. demonstrates that the
amino-terminal transcriptional activation domain of
C/EBP binds regions of CBP/p300 and PCAF through
the E1a binding domain (Mink et al., 1997). E1a com-
FIG. 6. LIP inhibits accessibility of restriction enzymes at the HIV-1 LTR. (A) U1 and UI-LIP cells were cultured in the absence or presence of PMA
for 12 h. Supernatants were collected and reverse transcriptase assays (RT) were performed to determine virus levels. (B) Schematic of HIV-1 LTR
showing positioned nucleosomes and relevant restriction enzyme sites. (C) Nuclei from U1 and U1-LIP cells were isolated following culture in the
absence (Lanes 1, 3, 5, 7) or presence of PMA (Lanes 2, 4, 6, 8) for 12 h. Genomic DNA was purified from nuclei following no restriction digest (Lanes
1–4) or HindIII digestion (Lanes 5–8). Restriction fragments were detected by LM-PCR as described under Materials and Methods. Lane 9 is a positive
control using NL43 cDNA digested with HindIII and Lane 10 is undigested NL43 DNA negative control. (D) Nuclei from U1 and U1-LIP cells digested
with PvuII. Lane 5 is NL43 cDNA digested with PvuII.
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pletely inhibits the ability of C/EBP to transactivate the
HIV-1 LTR, suggesting that E1a is competing with
C/EBP for binding to CBP/p300 or PCAF (Chakravarti et
al., 1999; Hamamori et al., 1999). Furthermore, the LIP
dominant-negative protein, which lacks this domain
(Mink et al., 1997), does not physically interact with PCAF,
fails to activate HIV-1 transcription, and is unable to
mediate the displacement of nucleosomes that repress
HIV-1 transcriptional initiation. Therefore, the HIV-1 LTR
is similar to other myeloid-specific promoters requiring
C/EBP and coactivators for differential activity (Kowenz-
Leutz and Leutz, 1999; Mink et al., 1997; Oelgeschlager et
al., 1996).
C/EBP has also been demonstrated to interact with
components of the basal transcriptional machinery such
as TBP and TFIIB (Nerlov and Ziff, 1995) and other tran-
scription factors, including NF-B and CREB (Hohaus et
al., 1995; LeClair et al., 1992; Ross et al., 2001; Stein et al.,
1993; Westendorf et al., 1998; Zhang et al., 1996). These
proteins may cooperate in the recruitment of coactivators
to the HIV-1 LTR in monocytic cells. Furthermore, the
recruitment of coactivators by transcription factors, in-
cluding C/EBP, may functionally impact Tat, which
physically interacts with HATs including CBP/p300,
PCAF, TAFII250, and Tip60 (Benkirane et al., 1998; Hotti-
ger et al., 1998; Kamine et al., 1996; Kiernan et al., 1999;
Marzio et al., 1998; Weissman et al., 1998). In addition to
recruiting HATs, C/EBP physically interacts with the
ATP-dependent chromatin remodeling complex Swi-Snf
(Kowenz-Leutz and Leutz, 1999) and therefore may coor-
dinate multiple factors that participate in establishing a
transcriptionally accessible HIV-1 LTR.
MATERIALS AND METHODS
Cell lines and expression constructs
U937, U937-LIP, U1, and U1-LIP pro-monocytic cell
lines were cultured in RPMI 1640 medium supplemented
with 10% fetal calf serum (FCS), 100 units/ml penicillin,
100 g/ml streptomycin, and 2 mM L-glutamine. U937
and U1 cells overexpressing LIP have been previously
described (Henderson et al., 1996; Henderson and Cal-
ame, 1997). 293T human embryonic kidney cell lines
were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% FCS, 100 units/ml pen-
icillin, 100 g/ml streptomycin, and 2 mM L-glutamine.
The LTR-luciferase reporter and the GST-C/EBP con-
structs have been previously described (Artandi and Ca-
lame, 1993; Henderson et al., 1995). The C/EBP expres-
sion construct was generated by subcloning C/EBP
cDNA from pSCT-LAP (Descombes and Schibler, 1991)
into the EcoRI site of the MSCV-IRES-GFP retroviral ex-
pression construct (generously provided by G. Nolan,
Stanford University) (Anderson et al., 1996). The CMV-LIP
construct has been previously described (Henderson et
al., 1996). The CBP expression construct was previously
described (Kwok et al., 1996) and was provided by Dr. R.
Goodman (Oregon Health Sciences University). Dr. D.
Livingston (Dana-Farber Cancer Institute, Harvard Uni-
versity) generously provided the 12s E1a expression con-
struct (White et al., 1991), and PCAF expression construct
(Yang et al., 1996) was obtained from Dr. Y. Nakatani
(National Institute of Child Health and Human Develop-
ment, Bethesda, MD).
Transient transfections and luciferase assays
293T cells were transfected with different DNA con-
structs as indicated in the figure legends by calcium
phosphate. Forty-eight hours posttransfection cells were
harvested, lysed, and assayed for luciferase activity us-
ing the Promega Reporter Assay System (Madison, WI).
Transfection efficiencies were determined by monitoring
GFP expression from either the MCSV-C/EBP-IRES-
GFP or the cotransfected MCSV-IRES-GFP. Protein ex-
pression was monitored by immunoblot as previously
described (data not shown) (Cooper et al., 1995).
Generation of HIV-1 infectious titers and infections
Replication-competent virus was generated by trans-
fecting 293T cells with 15 g T-tropic pHIV-EGFP RE
DNA and 3 g RSV-Rev DNA by CaPO4 transfection (Pear
et al., 1993). Production of viral particles was monitored
by RT activity 48 h posttransfection. Infectious virus
stocks were added to 1.0  106 cells/ml U937 and U937-
LIP cells for 24 h. The infection medium was then re-
moved and replaced with fresh RPMI supplemented with
10% FCS, 100 units/ml penicillin, 100 g/ml streptomycin,
and 2 mM L-glutamine. At various times postinfection,
infected cells were fixed with 2% paraformaldehyde and
quantitated using a Coulter flow cytometer at the Penn
State flow cytometry core facility.
Replication-incompetent virus was also generated
by transient transfection using 10 g of pNL43-
Luc()Env() (HIV-luc) DNA (Connor et al., 1995), 2 g
HXB2-Env DNA, and 2 g RSV-Rev DNA. Transfection
efficiency was assessed by luciferase activity. Two hun-
dred microliters of undiluted viral stocks was added to
1.0 106 cells/ml U937 and U937-LIP cells for 24 h. Cells
were harvested 48 h postinfection and assayed for viral
transcription by luciferase assays. 1.0  105 cells were
lysed in 1 Reporter Lysis Buffer (Promega) and super-
natants were collected. Twenty microliters of cell extract
was added to 100 l luciferase substrate (Promega) and
activity was measured using a luminometer.
Reverse transcriptase (RT) assays
Virus replication was measured by RT assays at vari-
ous times postinfection (Henderson et al., 1996). Briefly,
10 l of supernatant was added to a mixture containing
60 mM Tris, 24 mM DTT, 7 mM MgCl2, 75 mM NaCl, 6
g/ml poly(dG), 12 g/ml poly(rC), 0.06% NP-40, and 10
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Ci [-32P]dGTP in a final volume of 50 l and incubated
at 37°C for 1 h. Ten microliters of this reaction mixture
was then transferred to DEAE paper and washed twice in
2 SSC (0.3 M NaCl, 0.03 M Na citrate) for 15 min at 25°C.
RT activity was quantitated using a phosphorimager.
Immunofluorescent staining
To detect cell-surface receptors CD4 or CXCR4, 1.0 
106 U937 or U937-LIP cells were incubated in staining
media (1% FCS in PBS) with 1 g IgG1 isotype FITC-
conjugated mouse anti-human CD4 mAb (Pharmingen,
San Diego, CA) or 1 g IgG2a isotype PE-conjugated
mouse anti-human CXCR4 mAb (Pharmingen) for 30 min
at 4°C. Cells were washed three times in staining media
and fixed with 2% paraformaldehyde. Fluorescence was
measured using a Coulter flow cytometer at the Penn
State flow cytometry core facility.
RNA extraction and RT-PCR
Total RNA was prepared by lysing cells with 4 M
guanidinium thiocyanate, 25 mM sodium citrate (pH 7),
0.5% sarkosyl, and 0.1 M 2-mercaptoethanol followed by
a phenol-chloroform extraction (Chomczynski and Sac-
chi, 1987). cDNA was prepared from 2 g of RNA using
murine leukemia virus reverse transcriptase and random
primers. To amplify the cDNA, a 30-cycle polymerase
chain reaction of 94°C for 1 min, 55°C for 2 min, and
72°C for 3 min was performed with 0.2 g of cDNA using
various primers. CD4 cDNA was amplified using the
upstream primer 5-TGGTAGTAGCCCCTCAGTGC-3 and
downstream primer 5-CACCACCAGGTTCACTTCCT-3.
CXCR4 cDNA was amplified using the upstream primer
5-TTCCTGCCCACCATCTACTC-3 and downstream primer
5-CCATGATGTGCTGAAACTGG-3. -actin cDNA was
amplified using the upstream primer 5-CCTAAGGCC-
AACCGTGAAAAG-3 and downstream primer 5-TCT-
TCATGGTGCTAGGAGCCA-3.
PCR for proviral sequences
To detect proviral sequences in genomic DNA, U937
and U937-LIP cells were lysed 48 h postinfection with
TES buffer (10 mM Tris, pH 8.0, 400 mM NaCl, 2 mM
EDTA, 1% SDS) and treated with 0.5 mg/ml proteinase K
at 55°C for 5 h. Measures of 1, 0.1, or 0.01 g genomic
DNA were amplified by a 30-cycle PCR of 94°C for 1 min,
53°C for 2 min, 72°C for 2 min using the upstream primer
5-GCCTGCATGGGATGGA-3 and downstream primer
5-CCACTGCTAGAGATTTTCCAC-3 (Henderson et al.,
1996). PCR products were resolved on a 1% agarose gel.
Nuclear extract preparations and electromobility shift
assays (EMSA)
Nuclear extracts from 2.0  106 293T cells were pre-
pared as described previously (Schreiber et al., 1989) by
lysing cells with 10% Nonidet P-40 in buffer A [10 mM
HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA,
1 mM DTT, 0.5 mM PMSF]. Extracts were recovered in
buffer C [20 mM HEPES (pH 7.9), 0.4 M NaCl, 1mM EDTA,
1 mM EGTA, 1 mM DTT, 1 mM PMSF]. Fifty nanograms of
annealed C/EBP-binding site DNA (5-GATCGCCTAGC-
ATTTCATCACACGT-3 and 5-AGCTCCTGGAAAGTCCC-
CAG CGGAAAGTCCCTT 3) was end-filled with [-32P]-
dCTP using bacterial Klenow fragment (Promega). Four
micrograms of nuclear extract was incubated in a reac-
tion mixture containing the DNA probe, 3 g of poly-
(dIdC) (Amersham Pharmacia Biotech, Arlington Heights,
IL), 0.25 M HEPES (pH 7.5), 0.6 M KCl, 50 mM MgCl2, 1
mM EDTA, 7.5 mM DTT, and 9% glycerol for 20 min at
25°C. Fiftyfold excess of unlabeled C/EBP or NF-B bind-
ing site DNA was used as specific and nonspecific
competitors, respectively. The samples were run on a 6%
polyacrylamide gel and visualized by autoradiography.
Coimmunoprecipitation and Western blotting
Nuclear extracts from 293T cells transfected with 0 or
1 g PCAF and 0 or 5 g C/EBP or LIP were immuno-
precipitated with 1 g rabbit-anti-C/EBP polyclonal an-
tibody and 10 L protein A/G-agarose beads (Santa
Cruz). Complexes were washed four times with PBS and
resuspended in 50 L 1 SDS buffer [50 mM Tris–HCl
(pH 6.8), 2% SDS, 0.1% bromphenol blue, 10% glycerol,
100 mM DTT]. Ten microliters of each sample was run on
a 10% SDS–polyacrylamide gel and transferred to a ni-
trocellulose membrane (Schleicher and Schuell, Keene,
NH). Membrane was probed for PCAF using mouse-anti-
Flag monoclonal antibody (Sigma) for 1 h at 25°C and
horseradish peroxidase conjugated sheep anti-mouse
antibody (Chemicon, Temecula, CA) for 1 h at 25°C. For
detection of C/EBP proteins, membrane was stripped
with 100 mM -mercaptoethanol, 62.5 mM Tris–HCl (pH
6.7), 2% SDS for 1 h at 55°C and probed with rabbit
anti-C/EBP antibody (Santa Cruz) for 1 h at 25°C and
horseradish peroxidase conjugated goat anti-rabbit an-
tibody (Gibco) for 1 h at 25°C. Proteins were detected
using ECL Plus Western Blotting Detection system (Am-
ersham Pharmacia Biotech).
GST pull-down assay
GST and GST-C/EBP fusion products were purified
from bacterial extracts by binding to glutathione-Sepha-
rose 4B beads (Pharmacia) as described (Barlev et al.,
1995). SAGA complexes were obtained from Dr. J. Work-
man’s laboratory (Penn State) (Grant et al., 1997). Equiv-
alent amounts of SAGA, precleared with glutathione-
Sepharose beads, were incubated with immobilized GST
fusion proteins for 2 h at 4°C in binding buffer [50 mM
HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 0.1% Tween
20, 0.5 mM DTT, 1 mM PMSF, 2 g/ml leupeptin, 2 g/ml
pepstatin A]. The supernatants were removed and the
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beads were washed three times with binding buffer.
Input SAGA, supernatants, and beads were directly as-
sayed for HAT activity on histones (Grant et al., 1997).
Briefly, 2 g of core histones was incubated with 10 l of
sample to be tested and 3H-labeled acetyl-CoA (0.125
Ci) in HAT buffer [50 mM Tris–HCl (pH 8.0), 50 mM HCl,
5% glycerol, 0.1 mM EDTA, 1 mM DTT, 1 mM PMSF, 10
mM sodium butyrate] at 30°C for 30 min. The reactions
were then run on 18% SDS–polyacrylamide gel electro-
phoresis (SDS–PAGE) (Grant et al., 1997). Gels were
Coomassie stained to determine the amounts of histone
loaded in each lane and destained before determining
acetylation by fluorography using EN3HANCE autora-
diography enhancer (NEN, Boston, MA).
Restriction enzyme accessibility assay and
ligation-mediated PCR
U1 and U1-LIP cells were stimulated with phorbol
myristate acetate (PMA) for 48 h and HIV-1 transcription
was monitored by RT activity in the cell culture superna-
tant. Cells were harvested and resuspended at 2.5  107
cells/ml in cold buffer A [10 mM Tris–HCl (pH 7.4), 10 mM
NaCl, 3 mM MgCl2, and 0.3 M sucrose] for 5 min and
then lysed in 0.3% NP-40 for 30 s. Nuclei were collected
by centrifugation and resuspended in Buffer B [10 mM
Tris–HCl (pH 7.9), 10 mM MgCl2, 50 mM NaCl, 1 mM DTT,
100 g/ml BSA, and 0.1 mM PMSF]. Nuclei were digested
with 400 U of HindIII, PvuII, PstI, and HinfI (New England
Biolabs) for 8–16 h. Genomic DNA was prepared by
lysing nuclei with TES buffer [10 mM Tris (pH 8.0), 400
mM NaCl, 2 mM EDTA, and 1% SDS] and treating with
200 g/ml proteinase K at 55°C for 5 h. DNA was ex-
tracted once with 1 volume phenol, followed by a 1:1
phenol:chloroform:isoamyl alcohol extraction, and two
extractions with 24:1 chloroform:isoamyl.
Digested DNA fragments were detected using a liga-
tion-mediated PCR (LM-PCR) (Mueller and Wold, 1989).
The primer REDA (5 CTAGCATTTCATCACATGG3) (0.3
pmol/l) was used in an initial primer extension reaction
with 1–5 g of digested genomic DNA as a template, 40
mM NaCl, 0.01 M Tris–HCl (pH 8.9), 5 mM MgSO4, 0.01%
gelatin, 0.2 mM dNTPs, and 1 unit of Vent DNA polymer-
ase for one cycle of 95°C for 5 min, 49°C for 30 min, and
76°C for 15 min. Annealed linkers were prepared (LM1
primer, 5 GCTGTGACAAGGAGATCTGAATTC 3 and
LM2 primer, 5 GAATTCAGATC3) and 100 pmol was
ligated to extension products at 15°C using 1 unit T4
ligase in 3 mM ATP, 10 mM MgCl2, 0.02 M DTT, and 1.25
g BSA. DNA was precipitated before using in a PCR
reaction consisting of 10 pmol REDA-2 primer (5TG-
CATCCGGAGTACTTCAAGAAC3) and LM-1, 0.2 mM
dNTPs, 20 mM Tris–HCl (pH 8.9), 40 mM NaCl, 5 mM
MgSO4, 0.01% gelatin, and 0.1% Triton X-100, 1 unit Vent
DNA polymerase for 15 cycles at 95°C for 1 min, 63°C for
2 min, and 76°C for 4 min. PCR products were detected
by primer extension using 5 pmol of an end-labeled
primer (REDA-3; 5 GAGTACTTCAAGAACTGCTGACAT-
CG3), 0.2 mM dNTPs, 5 units of DNA Vent polymerase,
and a five-cycle reaction of 94°C for 40 s and 71°C for 3
min. The reaction was stopped by adding 0.1 M EDTA.
Products were precipitated with 0.3 M sodium acetate
and 100% ethanol before resolving on an 8% polyacryl-
amide gel and visualizing by audioradiography.
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